MannKind Corp. buy BiotechBee
Start price
08.09.24
/
60%
€5.49
Target price
28.02.27
€7.00
Performance (%)
17.70%
End price
14.12.24
€6.46
Summary
This prediction ended on 14.12.24 with a price of €6.46. The BUY prediction by BiotechBee finished with a performance of 17.70%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| MannKind Corp. | -10.882% | -10.882% | -50.854% |
| iShares Core DAX® | -0,98 % | -4,72 % | 4,79 % |
| iShares Nasdaq 100 | 1,16 % | 1,88 % | 20,23 % |
| iShares Nikkei 225® | -1,59 % | -5,39 % | 31,35 % |
| iShares S&P 500 | -0,28 % | 0,33 % | 13,91 % |
According to BiotechBee what are the pros and cons of MannKind Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread MannKind Corp. diskutieren
Buy mit Kursziel 7,0
In the thread Trading MannKind Corp.
Buy beendet

